House Foods Group (2810) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 Jul, 2026Executive summary
Net sales increased 1.3% year-over-year to 75,699 million yen for Q1 FY2025, but operating profit dropped 38.6% to 3,418 million yen and profit attributable to owners of parent fell 49.4% to 1,801 million yen.
International Food and Restaurant segments posted higher sales and profits, while Spice/Seasoning/Processed Food and Health Food segments saw significant profit declines due to rising raw material costs.
Comprehensive income plunged 84.1% year-over-year, mainly due to foreign currency translation losses.
Financial highlights
Gross profit margin decreased as cost of sales rose 3.8% year-over-year, outpacing net sales growth.
Operating profit margin fell to 4.5% from 7.5% a year ago.
EPS (basic) was 19.20 yen, down from 36.71 yen in Q1 FY2024.
Equity ratio improved to 68.2% from 67.3% at the end of the previous fiscal year.
Outlook and guidance
Full-year FY2025 guidance maintained: net sales 333,000 million yen (+5.6%), operating profit 21,500 million yen (+7.5%), profit attributable to owners of parent 13,000 million yen (+4.1%), EPS 137.98 yen.
No revisions to dividend or earnings forecasts.
Latest events from House Foods Group
- Sales and operating profit rose, but net profit fell due to last year's one-time gain.2810
Q1 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on one-off factors; record profit targeted.2810
Q2 202513 Jul 2026 - Sales and operating profit increased, but net profit dropped sharply on one-time items.2810
Q4 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on lower extraordinary gains; outlook unchanged.2810
Q3 202513 Jul 2026 - Profits fell on higher costs and weak demand, but stable dividends and a 2H recovery are forecast.2810
Q2 202613 Jul 2026 - Sales grew modestly, but profits declined due to rising costs and inflationary pressures.2810
Q3 202613 Jul 2026 - Profits fell on higher costs and U.S. impairments, but FY2027 profit set to rebound on asset sales.2810
Q4 202613 Jul 2026